MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies.
Tang BF, Xu WT, Fang SJ, Zhu JY, Qiu RF, Shen L, Yang Y, Weng QY, Wang YJ, Ding JY, Zhang XJ, Chen WQ, Zheng LY, Song JJ, Chen B, Zhao ZW, Chen MJ, Ji JS.
Tang BF, et al. Among authors: zheng ly.
Mil Med Res. 2025 Jan 27;12(1):5. doi: 10.1186/s40779-024-00588-7.
Mil Med Res. 2025.
PMID: 39871325